The impacts of bovine viral diarrhea virus (BVDv) and persistently infected (PI) are felt across the cattle industry. This project utilized data and parameters from a meta-analysis of reported results along with partial budgeting procedures to determine economic costs and benefits of herd and calf health management. A base herd of 100 head, consisting of 50 breeding females, 43 calves, and 7 replacement heifers and bulls was implemented. Ninety- six percent of cow-calf operations are uninfected from BVDv. Introduction of an enhanced health program as an uninfected herd resulted in a net loss of $7.64 per bred cow in the first year of the program and a net loss of $6.46 in year two. First-year costs were higher due to initial testing, while second-year costs did not include testing under the assumption that carriers were culled. Infected herds incurred net losses of health program implementation of $96.21 per bred cow for the first year but a gain of the program of $27.96 in year two. First-year losses were larger due to increased testing and eradication costs. Gains in the second year stemmed from increased productivity across the herd. Furthermore, gains were discovered beyond cow-calf operations. Evaluation of down-stream demand for calves (i.e., stocker operations) resulted in gains of $4.39 per stocker for a producer that retains ownership of their calves and $48.89 for producers purchasing calves from cow-calf operators (commercial). Commercial stocker operators benefited from fewer health issues without added cow-calf level costs. These results indicate cow-calf producers would carry the burden of the costs of managing, and attempting to eradicate, BVDv/PI across the industry. These results provide industry stakeholder groups and policymakers benchmarks for incentives to induce health programs, targeted largely at the cow-calf level
展开▼
